NexgenRx Inc (TSE:NXG) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NexgenRx Inc. reported a robust first quarter in 2024, showcasing a 24% increase in revenue to $4.3 million and substantial growth in net income and EBITDA, attributed to the successful introduction of SaaS solutions and a strong sales pipeline. The company celebrated its 20th anniversary with a record Q1 performance and a solid cash position, even after a significant dividend payout to shareholders.
For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.
